The North America CRISPR market is projected to record a CAGR of 20.05% during the forecasting years of 2021 to 2028. The market growth of the region is facilitated by the increased healthcare expenditure, the expanding biopharmaceutical research and development (R&D) endeavors, and the active engagement of numerous pharmaceutical firms towards developing novel therapies.

NORTH AMERICA CRISPR MARKET FORECAST 2021-2028

North America CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography

Request free sample

The North America CRISPR market is projected to record a CAGR of 20.05% during the forecasting years of 2021 to 2028. The market growth of the region is facilitated by the increased healthcare expenditure, the expanding biopharmaceutical research and development (R&D) endeavors, and the active engagement of numerous pharmaceutical firms towards developing novel therapies.north-america-crispr-market

To learn more about this report, request a free sample copy

The North America CRISPR market growth assessment constitutes the analysis of the United States and Canada. Human genetic engineering continues to witness highly regulated advancements. For instance, four clinical trials were launched in the United States in 2019 to utilize CRISPR for treating and potentially curing patients with serious medical conditions. The clinical trials in the country entail Phase 1 and 2 trials designed to demonstrate the efficacy and safety of a potential treatment. Typically, the make-or-break clinical trials use a drug from laboratories in order to test on real patients.

While some diseases that CRISPR therapies aim to tackle have other available treatments, a proportion of gene editing’s appeal is based on the likelihood of a more effective or even permanent solution. Besides, the United States’ clinical trials involving CRISPR may also deal with cancers including melanoma and lymphoma, blindness, and sickle cell disease. As a result, these factors are set to propel the CRISPR market growth in North America over the forecast period.

Caribou Biosciences Inc, headquartered in the United States, offers bio-based products as well as medical therapies. The company also provides microbial strains, therapeutic bioproduction, and agricultural biotechnology products. As a leading biotechnology company, it primarily operates in the field of genome engineering. The firm develops technology-oriented solutions for cellular engineering, in addition to the analysis based on the CRISPR-Cas9 technology platform.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISK OF CONGENITAL ANOMALIES
        • PREVALENCE OF GENETIC DISORDERS
        • GROWING USE OF CRISPR IN AGRICULTURE
        • RISING AWARENESS REGARDING GENE THERAPEUTICS
      • KEY RESTRAINTS
        • POSSIBLE MISUSE OF CRISPR GENE-EDITING TOOL
        • LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
        • ETHICAL ISSUES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CRISPR MARKET
      • PATENT ANALYSIS
      • FUNDING SCENARIO
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • COST
        • ACCURACY
        • EASY TO USE
      • LEGAL & REGULATORY FRAMEWORK
    2. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    4. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ADDGENE
        • CARIBOU BIOSCIENCES INC
        • CELLECTIS BIORESEARCH SAS
        • CRISPR THERAPEUTICS AG
        • EDITAS MEDICINE
        • GENSCRIPT
        • HORIZON DISCOVERY GROUP
        • INTEGRATED DNA TECHNOLOGIES
        • INTELLIA THERAPEUTICS
        • LONZA GROUP LTD
        • NEW ENGLAND BIOLABS
        • NOVARTIS INTERNATIONAL AG
        • ORIGENE TECHNOLOGIES INC
        • PRECISION BIOSCIENCES
        • SYNTHEGO CORPORATION
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CRISPR

    TABLE 2: FUNDING SCENARIO OF PUBLIC COMPANIES

    TABLE 3: FUNDING SCENARIO OF PRIVATE COMPANIES

    TABLE 4: FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS

    TABLE 5: REGULATORY FRAMEWORK

    TABLE 6: NORTH AMERICA CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: LEADING PLAYERS OPERATING IN NORTH AMERICA CRISPR MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: NORTH AMERICA CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 8: NORTH AMERICA CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 17: NORTH AMERICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 23: NORTH AMERICA CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 28: UNITED STATES CRISPR MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: CANADA CRISPR MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    3. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type